These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 4371765

  • 1. Behavioral effects of direct- and indirect-acting dopaminergic agonists.
    Moore KE.
    Adv Biochem Psychopharmacol; 1974; 12(0):403-14. PubMed ID: 4371765
    [No Abstract] [Full Text] [Related]

  • 2. Proceedings: Behavioral effects of direct and indirect acting dopaminergic agonists.
    Moore KE.
    Psychopharmacol Bull; 1974 Jul; 10(3):41-2. PubMed ID: 4419323
    [No Abstract] [Full Text] [Related]

  • 3. Apomorphine and amphetamine stereotypy after 6-hydroxydopamine lesions of the substantia nigra.
    Price MT, Fibiger HC.
    Eur J Pharmacol; 1974 Dec; 29(2):249-52. PubMed ID: 4613562
    [No Abstract] [Full Text] [Related]

  • 4. Behavioural sequelae of dopaminergic degeneration: postsynaptic supersensitivity?
    Creese I, Iversen SD.
    Psychopharmacol Bull; 1975 Oct; 11(4):12-3. PubMed ID: 1197588
    [No Abstract] [Full Text] [Related]

  • 5. Dopaminergic supersensitivity in the striatum.
    Ungerstedt U, Ljungberg T, Hoffer B, Siggins G.
    Adv Neurol; 1975 Oct; 9():57-65. PubMed ID: 167568
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Behavioral activation developing after cessation of electrical stimulation of the caudate nucleus].
    Shishliannikova LV.
    Fiziol Zh SSSR Im I M Sechenova; 1980 Aug; 66(8):1165-70. PubMed ID: 7191378
    [Abstract] [Full Text] [Related]

  • 9. Behavioral correlates of dopaminergic supersensitivity.
    Iversen SD, Creese I.
    Adv Neurol; 1975 Aug; 9():81-92. PubMed ID: 1170717
    [No Abstract] [Full Text] [Related]

  • 10. Mazindol anorexia is mediated by activation of dopaminergic mechanisms.
    Kruk ZL, Zarrindast MR.
    Br J Pharmacol; 1976 Nov; 58(3):367-72. PubMed ID: 990591
    [Abstract] [Full Text] [Related]

  • 11. The influence of acute and chronic administration of 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline on the function of the nigrostriatal dopaminergic system in rats.
    Lorenc-Koci E, Antkiewicz-Michaluk L, Kamińska A, Lenda T, Zieba B, Wierońska J, Smiałowska M, Schulze G, Rommelspacher H.
    Neuroscience; 2008 Oct 28; 156(4):973-86. PubMed ID: 18809471
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Relationship of dopamine neural systems to the behavioral alterations produced by 6-hydroxydopamine administration into brain.
    Cooper BR, Breese GR.
    Adv Biochem Psychopharmacol; 1974 Oct 28; 12(0):353-68. PubMed ID: 4609223
    [No Abstract] [Full Text] [Related]

  • 15. Relationship between asymmetries in striatal dopamine release and the direction of amphetamine-induced rotation during the first week following a unilateral 6-OHDA lesion of the substantia nigra.
    Robinson TE, Noordhoorn M, Chan EM, Mocsary Z, Camp DM, Whishaw IQ.
    Synapse; 1994 May 28; 17(1):16-25. PubMed ID: 8042143
    [Abstract] [Full Text] [Related]

  • 16. Sparing of behavior and basal extracellular dopamine after 6-hydroxydopamine lesions of the nigrostriatal pathway in rats exposed to a prelesion sensitizing regimen of amphetamine.
    Moroz IA, Peciña S, Schallert T, Stewart J.
    Exp Neurol; 2004 Sep 28; 189(1):78-93. PubMed ID: 15296838
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.